Evidence map›Paper›PMID 41756995›Full record

ArticlebioRxiv : the preprint server for biology2026

Blocking glutamine transport normalizes lymphatic vessels in hypoxic environments by attenuating glycolysis.

Ellie Johandes, Eva Hall, Tomas Harbut, Kaden Priebe, Margaret A Schwarz, Donny Hanjaya-Putra

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ellie JohandesBioengineering Graduate Program, University of Notre Dame, Notre Dame, IN 46556.ORCID 0000-0002-3537-143X
Eva HallBioengineering Graduate Program, University of Notre Dame, Notre Dame, IN 46556.ORCID 0000-0002-0091-1045
Tomas HarbutBioengineering Graduate Program, University of Notre Dame, Notre Dame, IN 46556.ORCID 0009-0001-1457-0798
Kaden PriebeBioengineering Graduate Program, University of Notre Dame, Notre Dame, IN 46556.ORCID 0009-0000-2087-6825
Margaret A SchwarzChemistry and Biochemistry, University of Notre Dame, IN 46556.ORCID 0000-0001-5924-7399
Donny Hanjaya-PutraBioengineering Graduate Program, University of Notre Dame, Notre Dame, IN 46556.ORCID 0000-0002-5403-544X

Funding

Engineering the Stem Cell Microenvironment for Lymphatic RegenerationR35GM143055 · NIGMS · UNIVERSITY OF NOTRE DAME · PI HANJAYA-PUTRA, DONNY · 2021 to 2025
$2.2M
NIGMS NIH HHS R35 GM143055
6 · The paper itself

Abstract

Dysfunctional lymphangiogenesis is a component of several diseases with hypoxic microenvironments, including secondary lymphedema and solid malignancies. These vessels are ineffective at draining interstitial fluid, resulting in complications such as increased inflammation, slowed wound healing, and, for cancer patients, increased risk of metastasis. Current treatments to normalize vasculature have negative effects on healthy vessels and do not specifically target lymphatic endothelial cells (LECs). As hypoxia is known to change endothelial cell metabolism, exploiting LEC-specific metabolic pathways may provide a focused approach to restoring lymphatic function in patients. However, outside of glycolysis, changes to LEC metabolism in hypoxic conditions are understudied. To address this gap in knowledge, we examined the impact of glutamine availability on factors critical to lymphangiogenesis, including glycolysis, cell proliferation, and migration. We found that increasing glutamine availability results in increased lactate production as well as a hypoxia-specific increase in glycolytic genes

Indexed as

Endothelial CellGlutamineGlycolysisHypoxiaLymphatic VesselsMetabolismVascular Remodeling

Identifiers

PMID41756995
PMCPMC12934653

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.